Tenet Healthcare Corporation (NYSE:THC) Receives $244.16 Average Target Price from Analysts

Tenet Healthcare Corporation (NYSE:THC) has been given a consensus recommendation of “Moderate Buy” by the twenty-two brokerages that are presently covering the company, MarketBeat reports. Three analysts have rated the stock with a hold rating and nineteen have issued a buy rating on the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $244.1579.

Several analysts recently commented on the company. Jefferies Financial Group raised their target price on Tenet Healthcare from $250.00 to $265.00 and gave the stock a “buy” rating in a report on Thursday, February 12th. Morgan Stanley set a $254.00 target price on Tenet Healthcare in a report on Friday, May 1st. Barclays dropped their target price on Tenet Healthcare from $257.00 to $238.00 and set an “overweight” rating on the stock in a report on Tuesday, May 5th. Robert W. Baird dropped their target price on Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating on the stock in a report on Tuesday, May 5th. Finally, Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Tenet Healthcare in a report on Friday, March 27th.

Tenet Healthcare Stock Up 0.6%

Shares of THC stock opened at $191.50 on Friday. The firm has a market capitalization of $16.50 billion, a PE ratio of 9.96, a P/E/G ratio of 1.27 and a beta of 1.30. Tenet Healthcare has a fifty-two week low of $146.60 and a fifty-two week high of $247.21. The stock’s 50-day simple moving average is $202.90 and its 200-day simple moving average is $204.02. The company has a debt-to-equity ratio of 1.96, a quick ratio of 1.30 and a current ratio of 1.36.

Tenet Healthcare (NYSE:THC) last posted its earnings results on Thursday, April 30th. The company reported $4.82 EPS for the quarter, topping the consensus estimate of $4.21 by $0.61. The firm had revenue of $5.37 billion for the quarter, compared to analyst estimates of $5.39 billion. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.Tenet Healthcare’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same period last year, the company earned $4.36 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Equities analysts expect that Tenet Healthcare will post 17.56 earnings per share for the current year.

Insider Buying and Selling at Tenet Healthcare

In other Tenet Healthcare news, EVP Thomas W. Arnst sold 8,000 shares of the firm’s stock in a transaction that occurred on Monday, March 9th. The stock was sold at an average price of $238.85, for a total value of $1,910,800.00. Following the sale, the executive vice president directly owned 12 shares of the company’s stock, valued at approximately $2,866.20. This trade represents a 99.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Paola M. Arbour sold 6,500 shares of the firm’s stock in a transaction that occurred on Wednesday, March 11th. The shares were sold at an average price of $238.43, for a total value of $1,549,795.00. Following the completion of the sale, the executive vice president directly owned 29,291 shares in the company, valued at approximately $6,983,853.13. The trade was a 18.16% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 46,517 shares of company stock valued at $10,943,111. Company insiders own 0.81% of the company’s stock.

Institutional Trading of Tenet Healthcare

Several institutional investors have recently bought and sold shares of the business. Wedmont Private Capital grew its holdings in Tenet Healthcare by 2.5% in the fourth quarter. Wedmont Private Capital now owns 2,088 shares of the company’s stock valued at $422,000 after purchasing an additional 50 shares during the period. Baron Wealth Management LLC lifted its position in shares of Tenet Healthcare by 4.8% in the fourth quarter. Baron Wealth Management LLC now owns 1,142 shares of the company’s stock valued at $227,000 after acquiring an additional 52 shares in the last quarter. PeakShares LLC lifted its position in shares of Tenet Healthcare by 3.3% in the first quarter. PeakShares LLC now owns 1,693 shares of the company’s stock valued at $319,000 after acquiring an additional 54 shares in the last quarter. Sagespring Wealth Partners LLC lifted its position in shares of Tenet Healthcare by 3.6% in the fourth quarter. Sagespring Wealth Partners LLC now owns 1,573 shares of the company’s stock valued at $313,000 after acquiring an additional 55 shares in the last quarter. Finally, Sanctuary Advisors LLC lifted its position in shares of Tenet Healthcare by 0.5% in the first quarter. Sanctuary Advisors LLC now owns 11,900 shares of the company’s stock valued at $2,246,000 after acquiring an additional 57 shares in the last quarter. 95.44% of the stock is owned by institutional investors and hedge funds.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.